Clinical trial

BE Study in Patients - Methotrexate Tablets

NCT02940561

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2016-08-01

PhasePHASE1

Study timeline

Study start (unknown)2016-08-01Date precision: month

Registry last updated2016-10-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Psoriasisunresolved

Rheumatoid Arthritisunresolved

Interventions

Methotrexate - AmnealDRUG

Methotrexate - DAVADRUG

Sponsors & collaborators

Amneal Pharmaceuticals, LLClead sponsor

Accutest Research Laboratories (I) Pvt. Ltd.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02940561 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.